MedPath

M.D. ANDERSON CANCER CENTER

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery

Not Applicable
Completed
Conditions
Esophageal Cancer
Lung Cancer
Interventions
Behavioral: Interactive Voice Response System
Other: Symptoms Report
First Posted Date
2007-07-20
Last Posted Date
2012-07-30
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
100
Registration Number
NCT00505024
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT MD Anderson Cancer Center, Houston, Texas, United States

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
First Posted Date
2007-07-20
Last Posted Date
2011-09-15
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
8
Registration Number
NCT00504634
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UT MD Anderson Cancer Center, Houston, Texas, United States

Gene Polymorphisms and Symptoms in Lung Cancer Patients

Completed
Conditions
Lung Cancer
Interventions
Behavioral: Questionnaire
First Posted Date
2007-07-20
Last Posted Date
2019-06-04
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
235
Registration Number
NCT00504374
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Fibrin Melanoma Axillary Node Study in Patients With Melanoma

Not Applicable
Completed
Conditions
Melanoma
Interventions
First Posted Date
2007-07-20
Last Posted Date
2023-05-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
121
Registration Number
NCT00504582
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device

Phase 1
Withdrawn
Conditions
Cervical Neoplasia
Interventions
Procedure: Multi-spectral Digital Colposcopy (MDC)
First Posted Date
2007-07-19
Last Posted Date
2016-04-08
Lead Sponsor
M.D. Anderson Cancer Center
Registration Number
NCT00503919

Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies

Conditions
Wilms' Tumor
Aniridia
Interventions
Behavioral: Questionnaire
Other: Blood specimen
First Posted Date
2007-07-19
Last Posted Date
2020-01-27
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
295
Registration Number
NCT00503893
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Proton Therapy With Capecitabine for Rectal Cancer

Phase 1
Withdrawn
Conditions
Rectal Cancer
Interventions
Procedure: Proton Therapy
Drug: Capecitabine
First Posted Date
2007-07-19
Last Posted Date
2012-03-22
Lead Sponsor
M.D. Anderson Cancer Center
Registration Number
NCT00503932

Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia

Completed
Conditions
Fatigue
Febrile Neutropenia
Solid Neoplasm
Interventions
Behavioral: Questionnaire
First Posted Date
2007-07-19
Last Posted Date
2018-10-22
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
70
Registration Number
NCT00503854
Locations
๐Ÿ‡บ๐Ÿ‡ธ

M D Anderson Cancer Center, Houston, Texas, United States

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

Phase 2
Completed
Conditions
Osteosarcoma
Interventions
Drug: Etoposide
Drug: Interferon Alpha
First Posted Date
2007-07-19
Last Posted Date
2012-08-02
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
30
Registration Number
NCT00504140
Locations
๐Ÿ‡บ๐Ÿ‡ธ

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Molecular Epidemiology of Acute Myelogenous Leukemia

Conditions
Leukemia
Interventions
Behavioral: Interview
First Posted Date
2007-07-18
Last Posted Date
2020-01-13
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
519
Registration Number
NCT00502983
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath